Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Collaboration to develop new Parkinson’s Disease dyskinesia treatment

September 6, 2006 Research and Development

Santhera Pharmaceuticals is collaborating with Finnish biotech company Juvantia Pharma to develop a treatment for dyskinesia, the distressing involuntary movements …
News

AstraZeneca and charity spin-off collaborate on colorectal cancer research

September 4, 2006 Research and Development

AstraZeneca is to work with a spin-off company set up by Cancer Research UK to research and develop new treatments …
News

Women’s European pharma network launched

September 1, 2006 Research and Development, Sales and Marketing Europe, association, pharma

 Over the years, the numbers of women taking up positions of authority in the pharmaceutical industry has grown considerably, and …
Feature

The right stuff: execs with the Midas touch

August 31, 2006 Business Services, Research and Development biotech, management, recruitment

Here's a challenge: find someone with PhD-level scientific knowledge, a strong management track record and entrepreneurial flair. If there are …
Feature

GSK signs $1.5 billion drug discovery deal

August 31, 2006 Research and Development

GlaxoSmithKline has formed an alliance with Californian biotech company ChemoCentryx through its innovative drug development partnering unit.A licensing deal has …
News

MabThera shows promise in multiple sclerosis

August 29, 2006 Research and Development

The blockbuster non-Hodgkin's lymphoma treatment MabThera could offer a new treatment option for people with multiple sclerosis according to new …
News

Time to get back to our scientific basics

August 23, 2006 Research and Development biotech, drug safety, industry reputation

Recently I was wandering through the local market, and found myself in front of a stall selling therapeutic magnets. I …
Feature

New broom Kindler sweeps away Pfizer bureaucracy

August 21, 2006 Research and Development, Sales and Marketing

Pfizer's new chief executive Jeffery Kindler has unveiled changes to the company's senior management structure just days into his new …
News

Head-to-head: Nice and the SMC

August 16, 2006 Research and Development, Sales and Marketing NICE, SMC, healthcare

The announcements on NHS budget deficits and the debates surrounding the prescribing of costly drugs, such as in the  Herceptin …
Feature

Vernalis takes diabetes pain drug into phase II

August 15, 2006 Research and Development Vernalis

UK biotech company Vernalis has started enrolment into a phase II trial of V3381, a drug designed for patients with …
News

NHS research could face

August 11, 2006 Research and Development

The British Medical Association is questioning the government over a possible 300 million pound drop in funding available for medical …
News

MDS named top clinical research company in Europe

August 1, 2006 Research and Development

MDS Pharma Services has been named Europe's best provider of clinical research services in a survey of trial investigators.Conducted by …
News

Tighter safeguards proposed for high-risk clinical trials

July 26, 2006 Research and Development

The expert group set up by the MHRA in the wake of the disastrous Northwick Park clinical trial has made …
News

Use your intelligence to watch the competition

July 25, 2006 Research and Development, Sales and Marketing market research

One of the reasons the executives of ill-fated US energy group Enron were for a while 'the smartest guys in …
Feature

Work progressing on Scotland’s ‘unique’ biotech campus

July 7, 2006 Research and Development

Plans to make Scotland a major centre for innovative biotech and pharmaceutical research are progressing, with a major new centre …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026